SCHEMBL7463955

SCHEMBL7463955

Cc1ccnc(N2CCN(C3CCC(n4ncc(=O)n(C)c4=O)CC3)CC2)n1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 10/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ HSD17B10 Q99714 4/20 0.41
▸ HPGD P15428 3/20 0.41
▸ HTR1A P08908 1/20 0.40
▸ GPR119 Q8TDV5 1/20 0.40
▸ TLR4 O00206 1/20 0.39
▸ TLR9 Q9NR96 1/20 0.39
▸ TLR8 Q9NR97 1/20 0.39
▸ TLR7 Q9NYK1 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ ACHE P22303 2/20 0.38
▸ SORD Q00796 1/20 0.38
▸ SLC6A7 Q99884 1/20 0.38
▸ MAPK1 P28482 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7472173 1.00 KDM4E (0.41) KDM4EALDH1A1HSD17B10HPGDHTR1A
SCHEMBL7465953 0.88 HTR1A (0.40) ALDH1A1HSD17B10HPGDHTR1ATLR4
SCHEMBL7468537 0.88 HTR1A (0.40) ALDH1A1HSD17B10HPGDHTR1ATLR4
SCHEMBL7465222 0.87 KDM4E (0.40) KDM4EALDH1A1HSD17B10HPGDHTR1A
SCHEMBL7465230 0.87 KDM4E (0.40) KDM4EALDH1A1HSD17B10HPGDHTR1A
SCHEMBL7462055 0.87 HTR1A (0.53) ALDH1A1HTR1A
SCHEMBL7471162 0.87 HTR1A (0.53) ALDH1A1HTR1A
SCHEMBL7462048 0.87 HTR1A (0.53) ALDH1A1HTR1A
SCHEMBL15345017 0.81 SORD (0.51) KDM4EALDH1A1HSD17B10HPGDPOLB
SCHEMBL7462483 0.80 HTR1A (0.41) ALDH1A1HSD17B10HTR1ATLR4TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1023273-B1 CYCLOHEXANE DERIVATIVES DIFUNCTIONALISED IN 1,4 AS LIGANDS OF 5HT1A RECEPTORS PF MEDICAMENT (FR) 2002-06-05 — — EP claimed
US-6191130-B1 HYPOTENSIVE AGENTS; THERAPY FOR SEXUAL DISORDERS; CENTRAL NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS PIERRE FABRE MEDICAMENT (FR) 2001-02-20 — — US claimed
EP-1023273-A1 CYCLOHEXANE DERIVATIVES DIFUNCTIONALISED IN 1,4 AS LIGANDS OF 5T H1A RECEPTORS PIERRE FABRE MEDICAMENT (FR) 2000-08-02 — — EP claimed
WO-1999020613-A1 CYCLOHEXANE DERIVATIVES DIFUNCTIONALISED IN 1,4 AS LIGANDS OF 5T H1A RECEPTORS PIERRE FABRE MEDICAMENT (FR) 1999-04-29 — — WO claimed
US-6191130-B1 HYPOTENSIVE AGENTS; THERAPY FOR SEXUAL DISORDERS; CENTRAL NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS PIERRE FABRE MEDICAMENT (FR) 2001-02-20 — — US disclosed
Send feedback